Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Hematological Oncology|May 25, 2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, et al.Annals of Hematology|December 25, 2019
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatmentsAlessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.European Journal of Haematology|June 30, 2011
Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromesPatrizia Falco, Alessandro Levis, Alessandra Stacchini, et al.Cancer Medicine|October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysisEnrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating AgentsSophie Park, Jean-François Hamel, Andrea Toma, et al.Pageof 2